Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [1] PROTHROMBIN COMPLEX CONCENTRATE (KCENTRA®) FOR REVERSAL OF ORAL FACTOR XA INHIBITORS
    Stratman, Rachel
    Owen, Emily
    Gibson, Gabrielle
    Human, Theresa
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [2] Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate
    Lipari, Louis
    Yang, Sam
    Milligan, Brian
    Blunck, Joseph
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (12): : 2641 - 2645
  • [3] 3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
    Hays, William Blake
    Billups, Kelsey
    Nicholson, Jessica
    Bailey, Abby M.
    Gregory, Haili
    Weeda, Erin R.
    Weant, Kyle A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025, 58 (02) : 276 - 283
  • [4] FIXED-DOSE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE FOR ORAL FACTOR XA INHIBITOR REVERSAL
    Hobbs, Brandon
    Liu-DeRyke, Xi
    Giancarelli, Amanda
    Birrer, Kara
    Spink, Tyler
    CRITICAL CARE MEDICINE, 2020, 48
  • [5] Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects
    Tanaka, Kenichi A.
    Levy, Jerrold H.
    BRITISH JOURNAL OF ANAESTHESIA, 2024, 132 (02) : 215 - 217
  • [6] Evaluation of fixed dose four-factor prothrombin complex concentrate for warfarin reversal at a level 1 trauma center
    H Drone
    J Jancik
    J Gorlin
    M McCarthy
    Critical Care, 19 (Suppl 1):
  • [7] Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study
    Estroff, Jordan M.
    Devlin, Joseph
    Hoteit, Lara
    Hassoune, Adnan
    Neal, Matthew D.
    Brown, Joshua B.
    Lu, Liling
    Kotch, Shannon
    Hazelton, Joshua P.
    Christian, Ashton B.
    Yeates, Eric O.
    Nahmias, Jeffry
    Jacobson, Lewis E.
    Williams, Jamie
    Schuster, Kevin M.
    O'Connor, Rick
    Semon, Gregory R.
    Straughn, Angela D.
    Cullinane, Daniel
    Egodage, Tanya
    Kincaid, Michelle
    Rollins, Allison
    Amdur, Richard
    Sarani, Babak
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2024, 97 (04): : 541 - 545
  • [8] Four-factor prothrombin complex concentrate for the reversal of factor Xa inhibitors for traumatic intracranial hemorrhage
    Dybdahl, Daniel
    Walliser, Grant
    Spalding, M. Chance
    Pershing, Michelle
    Kincaid, Michelle
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (10): : 1907 - 1911
  • [9] Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re-appraisal
    Dzik, W. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : S187 - S194
  • [10] FOUR FACTOR PROTHROMBIN CONCENTRATE UTILIZATION AT A LEVEL 1 TRAUMA CENTER
    Grunvald, Miles
    Fabricant, Loic
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E22 - E23
12345